中华内科杂志2023年2月第62卷第2期Chin J Intem Med.February2023.Vol.62,Na.2·129·标准与讨论·中国纤维肌痛综合征诊疗指南中华中医药学会风湿病分会海峡两岸医药卫生交流协会风湿免疫病学专业委员会纤雏肌痛综合征中西医研究学组首都中西医结合风湿免疫病研究所通信作者:姜泉,中国中医科学院广安门医院风湿病科,北京100053,Email:doctorjq@126.com;黄慈波,深圳大学附属华南医院风湿免疫科,深圳518061,Email:huangcibol2208@l39.com;曾小峰,中国医学科学院北京协和医学院北京协和医院风湿免疫科,北京100730,Email:zengxfpumc(@163.com【摘要】纤维肌痛综合征(FMS)是一种临床常见疾病,目前我国尚缺少大样本的流行病学数据,临床诊治亦存在诸多难点,制订我国下FMS的诊疗指南势在必行。中华中医药学会风湿病分会、海峡两岸医药卫生交流协会风湿免疫病学专业委员会纤维肌痛综合征中西医研究学组、首都中西医结合风湿免疫病研究所联合牵头发起,采用推荐意见分级的评估、制订及评价(GRADE)分级体系及国际实践指南报告标准(RIGHT),对我国一线医师关注的FMS的11个临床问题,给出了较为详细的循证推荐意见,旨在推动风湿免疫科、心理科、疼痛科等相关科室高度重视FMS的综合管理及早期识别与干预,早筛查、早评估、早治疗,提高患者的生活质量。【关键词】纤维肌痛;诊断;治疗;指南Chinese recommendations for the management of fibromyalgia syndromeChina Association of Chinese Medicine Rheumatology Society,Fibromyalgia Research Group ofTraditional Chinese and Western Medicine in Rheumatology and Immunology,Capital Institute ofRheumatology and Immunology of Integrated Chinese and Western MedicineCorresponding authors:Jiang Quan,Department of Rheumatology,Guang'anmen Hospital,ChinaAcademy of Chinese Medical Sciences Beijing 100053,China,Email:doctorjq@126.com;Huang Cibo,Department of Rheumatology,South China Hospital of Shenzhen University,Shenzhen 518061,China,Email:huangcibo1208@139.com:Zeng Xiaofeng,Department of Rheumatology and ClinicalImmunology,Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy ofMedical Sciences,Beijing 100730,China,Email:zengxfpumc@163.comAbstract Fibromyalgia syndrome (FMS)is a common clinical syndrome.At present,the lack of epidemiological data from large-sample studies in our country persists,and there aremany difficulties in diagnosis and treatment.It is imperative to formulate diagnosis and treatmentguidelines for FMS in our country.As such,a project was jointly initiated by the China Associationof Chinese Medicine Rheumatology Society,the Fibromyalgia Research Group of TraditionalChinese and Western Medicine in Rheumatology and Immunology,and the Capital Institute ofRheumatology and Immunology of Integrated Chinese and Western Medicine,which adopted theGrading of Recommendations Assessment,Development,and Evaluation grading system and theReporting Items for Practice Guidelines in Health Care for guideline development.Detailedevidence-based recommendations on 11 clinical problems of FMS that concern Chinese first-linephysicians are given in the guideline,aiming to encourage the departments of rheumatology,psychology,pain,and other related departments to attach great importance to the comprehensivemanagement,early identification and intervention,and assessment of FMS to improve the qualityD01:10.3760/cma.j.cnl12138-20220602-00426收稿日期2022-06-02本文编辑胡朝晖引用本文:中华中医药学会风湿病分会,海峡两岸医药卫生交流协会风湿免疫病学专业委员会纤维肌痛综合征中西医研究学组,首都中西医结合风湿免疫病研究所.中国纤维肌痛综合征诊疗指南】.中华内科■於志,2023,622k129-146.D0L10.3760/ema.j.cm112138-20220602-00426.